Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Stephen P. Mayock"'
Publikováno v:
Clinical Drug Investigation
Background and Objective Extended-release (ER) opioids are associated with high rates of abuse. Recreational opioid users often manipulate ER formulations to achieve a high plasma concentration in a short amount of time, resulting in a more rapid and
Autor:
Michael Grima, Stephen P. Mayock, Said Saim, Ernest A. Kopecky, Ravi K. Varanasi, Alison B. Fleming, Patrick K. Noonan
Publikováno v:
Journal of Opioid Management. 10:233-246
Objective: In vitro: To assess the effect of common crushing techniques on particle size reduction (PSR) and in vitro drug-release kinetics of oxycodone DETERx® (herein DETERx) and of a commercially available oxycodone extended-release (ER) tablet.
Publikováno v:
Clinical Drug Investigation
Publikováno v:
Journal of opioid management. 12(1)
Objective: Abuse of prescription analgesics is a well-recognized problem, with nearly 2 million people aged 12 years or older initiating nonmedical use of pain relievers in 2012. The prevalence of opioid abuse via intravenous (IV) injection has led t
Publikováno v:
Clinical Drug Investigation. 37:1203-1203
Autor:
Ernest A. Kopecky, Said Saim, Douglas R. Carlson, Ravi K. Varanasi, Michael Grima, Alison B. Fleming, Stephen P. Mayock
Publikováno v:
Pain practice : the official journal of World Institute of Pain. 16(3)
Background Patients who have chronic pain with dysphagia (difficulty swallowing) (CPD) often have difficulty taking oral medication and, as such, alter their medications by crushing or chewing in an attempt to make it easier to swallow. Such manipula
Publikováno v:
Drug and Alcohol Dependence. 140:e109